The French IVD market
This article was originally published in Clinica
Executive Summary
The French in vitro diagnostic (IVD) market is the second largest in Europe, with a value of over $2.4bn in 2008. It is also one of the most sophisticated markets in the world in terms of the technology used and patient access to diagnostic tests. Continued growth in this market is expected due to the emergence of pharmacogenetics, infectious disease controls and the rise of personalised medicine.